针刺治疗复发缓解型多发性硬化疲劳的随机对照试验
该随机对照试验纳入60例复发缓解型多发性硬化(RRMS)伴疲劳患者,比较针刺联合金刚烷胺与单用金刚烷胺的疗效。针刺组每周2至3次、共10次治疗4周后,疲劳严重度量表(FSS)评分改善显著优于对照组(P<0.01,MD=-1.14,95%CI:-1.83至-0.45),生活质量(MSQOL-54)亦显著改善(P<0.05,MD=9.09,95%CI:0.46至17.73),且无不良事件发生。
要点
- 针刺联合金刚烷胺可短期减轻RRMS患者疲劳,FSS改善优于单用金刚烷胺。
- 联合治疗还改善生活质量(MSQOL-54)的精神与躯体状态。
- 试验中针刺方案为每周2至3次、共10次、持续4周,未见不良事件。
核心结论
- 针刺联合金刚烷胺及常规免疫调节治疗,相比单用金刚烷胺及常规治疗,似为减轻RRMS患者疲劳及改善生活质量的短期有效疗法。
研究设计与样本
- 随机对照试验,纳入60例处于疾病缓解期、伴疲劳的复发缓解型多发性硬化(RRMS)患者,随机均分为针刺组(n=30)与对照组(n=30)。
- 针刺组每周治疗2至3次,4周内共10次;两组均接受金刚烷胺100 mg每日及常规免疫调节剂治疗。
主要发现
- 两组疲劳严重程度均下降,但治疗4周后针刺组疲劳改善较对照组更显著(P<0.01,MD=-1.14,95%CI:-1.83至-0.45)。
- 针刺组生活质量(含精神与躯体状态)较对照组显著改善(P<0.05,MD=9.09,95%CI:0.46至17.73)。
- 所有参与者均未发生不良事件。
关键数值与推荐
- 主要结局为疲劳严重度量表(FSS)评分,于基线、第2周和第4周评估。
- 次要结局为多发性硬化生活质量54(MSQOL-54)问卷评分,于基线和4周治疗结束时测量。
临床怎么用
- 对RRMS缓解期伴疲劳患者,可考虑在金刚烷胺及常规免疫调节治疗基础上联合针刺,每周2至3次、共10次、持续4周。
- 治疗期间可关注FSS与MSQOL-54评分变化以评估短期疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fatigue is experienced by more than 65% of individuals with multiple sclerosis (MS). Some studies have supported the effectiveness of acupuncture in improving the symptoms of MS. OBJECTIVE: The present research was intended to investigate the effectiveness of acupuncture plus amantadine compared with amantadine alone on fatigue in patients with relapsing-remitting MS (RRMS) in the remission stage of the disease. METHODS: In this randomized controlled trial, 60 participants with RRMS suffering from fatigue were recruited and randomized equally to acupuncture (n = 30) and control (n = 30) groups. The acupuncture group received treatment 2 to 3 times per week for 10 sessions over 4 weeks. Both the acupuncture and control groups received amantadine 100 mg daily and routine treatment with immuno-modulators. The primary outcome was the fatigue severity scale (FSS) score, which was evaluated at baseline, and after 2 and 4 weeks. The secondary outcome was the Multiple Sclerosis Quality of Life 54 (MSQOL-54) questionnaire score, measured at baseline and the end of the 4-week treatment period. RESULTS: The severity of fatigue was reduced in both groups. However, after 4 weeks of treatment, the reduction of fatigue in the acupuncture group was more significant than in the control group (P < 0.01, mean difference (MD) = -1.14, 95% confidence interval (CI): -1.83 to -0.45). Quality of life, including mental and physical status, was significantly improved in the acupuncture group compared with the control group (P < 0.05, MD = 9.09, 95% CI: 0.46 to 17.73). No adverse events occurred in any of the participants. CONCLUSIONS: Acupuncture combined with amantadine and routine care compared with amantadine and routine care alone appears to be an effective short-term treatment for reducing fatigue and enhancing quality of life, including physical function and mental status, in patients with RRMS.
引用
- Khodaie F, Naser Moghadasi A, Kazemi AH, et al. Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial. Acupunct Med. 2023. PMID: 36722418. doi:10.1177/09645284221150824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。